Bambang Budiono offers a detailed perspective on the Bioadaptor RCT two-year data, shedding light on the significant advancements and clinical outcomes associated with this innovative technology. In this video, Budiono discusses the pivotal role of the Bioadaptor in enhancing arterial health and improving patient experiences. Explore the transformative impact of this cutting-edge solution in the realm of cardiovascular treatment.
The opinions expressed here belong solely to the physician and do not reflect the views of Elixir Medical Corporation.
DynamX, Elixir are registered trademarks in the US and internationally for Elixir Medical Corporation.
DynamX Coronary Bioadaptor System is CE Mark. Not approved in the U.S.
©2024 Elixir Medical. All rights reserved.
International (OUS) Use Only. DynamX is intended to improve coronary luminal diameter in patients with symptomatic ischemic heart disease due to discrete de novo native coronary artery lesions. CAUTION: The law restricts this device to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device.